Cronos (TSX:CRON) Stock: $0 or $30?

Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) is a millionaire-maker stock. The only problem is that it’s also a millionaire-destroyer stock. It all depends on timing. In 2016, shares traded at $0.20. At the start of 2019, they touched $30. In just three years, a $5,000 investment became $750,000. Then the cannabis bear market of 2019 occurred. The industry lost billions of dollars…

Read More

Turn $1,000 Into $4,000 With This Pot Stock

Everyone wants to find a multi-bagger stock. That’s an investment that could double, triple, or even quadruple in value. These opportunities aren’t easy to find, but one pot stock looks the part. Before we jump into the stock pick, it’s critical to understand the recent history of marijuana. A volatile beginning In 2018, Canada passed the Cannabis Act, which paved…

Read More

Will Altria Buy Out Cronos (TSX:CRON) Stock?

Altria Group (NYSE:MO) is a giant company. Now valued at $70 billion, the tobacco behemoth has advantages that smaller competitors simply don’t possess. In today’s environment, Altria’s access to capital is most prized of all. There’s a chance the company could use its power to completely acquire its cannabis partner, Cronos Group Inc (TSX:CRON)(NASDAQ:CRON). In December of 2018, Altria and Cronos…

Read More

Will Cronos (TSX:CRON) Stock Fall Below $5?

Cronos Group (TSX:CRON)(NASDAQ:CRON) was once the hottest pot company in the world. From late 2014 to early 2019, Cronos stock rose in value by nearly 4,000%. The marijuana bear market of 2019 changed everything. Last year, virtually every pot stock lost more than 50% of its value. Cronos went from a $12 billion company to a valuation of less than…

Read More

Cronos Group (TSX:CRON) Stock: 1 Management Decision That Delays Growth in the U.S. Market

Cronos Group (TSX:CRON)(NASDAQ:CRON) finally reported its delayed fourth0quarter and full-year 2019 results on March 30. Much to investors’ disappointment, the company’s quarterly revenue growth in Canada was negative and massive inventory charges drowned spirits. There’s one more piece of information that could warrant a downward revision to the marijuana firm’s potential revenue growth rate. For a start, this was the…

Read More

Cronos Group Stock Price to Suffer an Earnings Restatement Penalty

Cronos Group (TSX:CRON)(NASDAQ:CRON) stock price fell by 12% early on Wednesday to give up some of its near 13% gains on Tuesday after the marijuana firm said it will effect a 40% charge on its third quarter 2019 revenue and will make a similar adjustment in its restated Q1 2019 earnings results. Cronos will reduce its first-quarter and third-quarter revenues…

Read More

Why the Cronos Group Stock Price Fell 18.3% in February

The Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) stock price fell 18.3% in February. The market continues to fall and company-specific uncertainty remains high. This is making any prediction for the Cronos Group stock price very uncertain and precarious. Fears of the potential severity of the coronavirus have ruled the market since February. This certainly continues today. As I write this article, I…

Read More

Why Is Cronos Group (TSX:CRON) Delaying Its Earnings Results?

Cannabis producer and innovation giant Cronos Group (TSX:CRON)(NASDAQ:CRON) announced on Monday that it will delay the release of its fourth quarter and full year 2019 earnings results originally slated for Thursday, February 27 as it has experienced a delay. No reason was given for the earnings release postponement, no new specific date was given for the delayed filings and the…

Read More

Is Cronos (TSX:CRON) Stock a Solid Long-Term Bet?

Cannabis investors have lost a significant portion of their investment since the last quarter of 2018. Investors were rightly concerned over the high valuation metrics of pot stocks, and this started the bear run for marijuana companies. Further, the revenue estimates for most cannabis companies seemed to have been overstated, as most analysts failed to consider the impact of Canada’s…

Read More

Will Cronos (TSX:CRON) and Altria (NYSE:MO) Take Over the Cannabis Market?

Few cannabis stocks are better positioned than Cronos Group (TSX:CRON)(NASDAQ:CRON). That’s because it has the backing of one of the most powerful, well-financed, most influential companies on the planet: Altria Group (NYSE:MO). Today, Altria is responsible for more than half of all U.S. cigarette sales. Its market cap exceeds $100 billion. That’s larger than every Canadian pot stock combined. With a $3…

Read More